Near-Death Quality of Life in Cancer Patients on Home Parenteral Nutrition

Overview

Journal Nutrients

Date 2025 Jan 25

PMID 39861401

Authors

Paolo Cotogni

Luca De Carli

Affiliations

Soon will be listed here.

Abstract

The impact of home parenteral nutrition (HPN) on the quality of life (QoL) of cancer patients has been previously investigated. However, scarce data are available regarding near-death QoL in patients with cancer receiving HPN. This study aims to investigate the changes of QoL in these patients in the last two months before death. This is a secondary analysis of a previous, prospective, longitudinal, observational study. QoL was assessed using the EORTC QLQ-C30 questionnaire. Eighty-four adult cancer patients who died on HPN and had filled out the questionnaire between 31 and 60 days (M2) and within 30 days prior (M1) to death were included in this analysis. The questionnaires filled out at M2 and M1 were compared with those filled out by the same patients at HPN start (T0). At M2, there was a significant improvement in both the global QoL and symptoms scales ( < 0.001 and < 0.033, respectively), while at M1, a significant improvement in the global QoL scale persisted ( < 0.035) compared with T0. Our study first reports that HPN, if started early and according to European guidelines, is associated with an improvement in the QoL of patients with cancer even in the last two months before death.

References

Ottery F . Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996; 12(1 Suppl):S15-9. DOI: 10.1016/0899-9007(96)90011-8. View

Reid J, McKenna H, Fitzsimons D, McCance T . Fighting over food: patient and family understanding of cancer cachexia. Oncol Nurs Forum. 2009; 36(4):439-45. DOI: 10.1188/09.ONF.439-445. View

Fearon K, Strasser F, Anker S, Bosaeus I, Bruera E, Fainsinger R . Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489-95. DOI: 10.1016/S1470-2045(10)70218-7. View

Ottery F . Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol. 1995; 22(2 Suppl 3):98-111. View

OGorman P, McMillan D, McArdle C . Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer. 1999; 32(2):76-80. DOI: 10.1080/01635589809514722. View

Kao J, Zucker A, Urso M, Karwowski P, Jain N, Jain S . Improving Survival Prognostication in Patients With Metastatic Cancer Through Clinical Judgment. Anticancer Res. 2022; 42(3):1397-1401. DOI: 10.21873/anticanres.15609. View

Marin Caro M, Laviano A, Pichard C, Candela C . [Relationship between nutritional intervention and quality of life in cancer patients]. Nutr Hosp. 2007; 22(3):337-50. View

Arends J, Baracos V, Bertz H, Bozzetti F, Calder P, Deutz N . ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017; 36(5):1187-1196. DOI: 10.1016/j.clnu.2017.06.017. View

Mattox T . Treatment of unintentional weight loss in patients with cancer. Nutr Clin Pract. 2005; 20(4):400-10. DOI: 10.1177/0115426505020004400. View

10.

Bjordal K, de Graeff A, Fayers P, Hammerlid E, van Pottelsberghe C, Curran D . A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000; 36(14):1796-807. DOI: 10.1016/s0959-8049(00)00186-6. View

11.

Sitlinger A, Zafar S . Health-Related Quality of Life: The Impact on Morbidity and Mortality. Surg Oncol Clin N Am. 2018; 27(4):675-684. PMC: 6428416. DOI: 10.1016/j.soc.2018.05.008. View

12.

Raijmakers N, van Zuylen L, Costantini M, Caraceni A, Clark J, Lundquist G . Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol. 2011; 22(7):1478-1486. DOI: 10.1093/annonc/mdq620. View

13.

Cotogni P, De Carli L, Passera R, Amerio M, Agnello E, Fadda M . Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Med. 2017; 6(7):1799-1806. PMC: 5504329. DOI: 10.1002/cam4.1111. View

14.

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F . ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2016; 36(1):11-48. DOI: 10.1016/j.clnu.2016.07.015. View

15.

Arends J . Malnutrition in cancer patients: Causes, consequences and treatment options. Eur J Surg Oncol. 2023; 50(5):107074. DOI: 10.1016/j.ejso.2023.107074. View

16.

Whitworth M, Whitfield A, Holm S, Shaffer J, Makin W, Jayson G . Doctor, does this mean I'm going to starve to death?. J Clin Oncol. 2004; 22(1):199-201. DOI: 10.1200/JCO.2004.02.056. View

17.

King L, Carson L, Konstantinides N, House M, ADCOCK L, Prem K . Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecol Oncol. 1993; 51(3):377-82. DOI: 10.1006/gyno.1993.1307. View

18.

Erickson N, Sullivan E, Kalliostra M, Laviano A, Wesseling J . Nutrition care is an integral part of patient-centred medical care: a European consensus. Med Oncol. 2023; 40(4):112. PMC: 9992033. DOI: 10.1007/s12032-023-01955-5. View

19.

Peppercorn J, Smith T, Helft P, Debono D, Berry S, Wollins D . American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011; 29(6):755-60. DOI: 10.1200/JCO.2010.33.1744. View

20.

Isenring E, Capra S, Bauer J . Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer. 2004; 91(3):447-52. PMC: 2409852. DOI: 10.1038/sj.bjc.6601962. View